National Stem Cell Manufacturing Facility
A dedicated facility to produce cellular therapeutic products according to current Good Manufacturing Practice (GMP).
The REMEDI GMP Facility is a state of the art cGMP facility, where clinical trial product will be manufactured. The facility has a floor space of 250m2 and consists of two parallel production suites. Each suite consists of three EU cGMP Annex 1 certified Grade B production cleanrooms, with Grade A isolators within each. Each room is equipped with fully validated equipment, necessary for the production of the clinical products. Each suit is controlled by separate air handling units and so this can facilitate the production of two different products in each suite at the same time.
The facility aims to bring the research work carried out in the REMEDI laboratories and translate this research into clinical product. The main disease focuses are Osteoarthritis, Diabetes and Peripheral Vascular Disease.
The Facility has been funded by Science Foundation Ireland (SFI) and also The Higher Education Authority (HEA).
The facility has a full team of qualified staff:
Director: Professor Timothy O’Brien
Scientific Director: Professor Frank Barry
Quality Person: Geraldine Walsh
Quality Manager: Marc Eglon
Production Manager: Aoife Duffy
Facility Manager: Dr Karen Duffy
Facility Engineer: Alan Leahy (Vector FM)
Six Production Operators
For further information contact:
Dr. Karen Duffy
Facility Manager
Tel: + 353 91 495326
Fax: + 353 91 495547
Email: karen.duffy@remedi.ie
Prof. Timothy O' Brien,
Facility Director
Tel: +353 91 495166
Fax: +353 91 495547
Email: timothy.obrien@remedi.ie



